AVDL · Insider Trading
Avadel Pharmaceuticals plc Ordinary Share
Every open-market purchase and sale reported by AVDL officers, directors and 10%+ beneficial owners on SEC Form 4, which must be filed within two business days of the transaction. Sales often reflect scheduled 10b5-1 plans or tax withholding rather than a directional view, so read counts alongside the size and the filer.
| Filed | Insider | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-02-12 | Susan Rodriguez | Chief Operating Officer | D | −300,000 deriv. | — |
| 2026-02-12 | Naseem Amin | Director | D | −22,000 | −$462.00K |
| 2026-02-12 | Peter J. Thornton | Director | D | −115,060 | −$2.42M |
| 2026-02-12 | Eric J Ende | Director | D | −219,905 | −$4.62M |
| 2026-02-12 | Thomas S McHugh | Chief Financial Officer | D | −100,400 | −$2.11M |
| 2026-02-12 | Jerad G. Seurer | Gen. Counsel & Corp. Secretary | D | −23,496 | −$493.42K |
| 2026-02-12 | Gregory J Divis | Chief Executive Officer | D | −221,105 | −$4.64M |
| 2026-02-12 | Geoffrey Michael Glass | Director | D | −166,984 | −$3.51M |
| 2026-02-12 | Linda Palczuk | Director | D | −78,905 | −$1.66M |
| 2026-02-12 | Mark Anthony McCamish | Director | D | −89,025 | −$1.87M |
| 2026-02-06 | Mark Anthony McCamish | Director | G | — | — |
| 2025-09-15 | Linda Palczuk | Director | G | −11,000 deriv. | — |
| 2025-09-15 | Geoffrey Michael Glass | Director | G | −11,000 deriv. | — |
| 2025-07-31 | Linda Palczuk | Director | A | +11,000 | — |
| 2025-07-31 | Eric J Ende | Director | A | +11,000 | — |
| 2025-07-31 | Peter J. Thornton | Director | A | +11,000 | — |
| 2025-07-31 | Mark Anthony McCamish | Director | A | +11,000 | — |
| 2025-07-31 | Naseem Amin | Director | A | +11,000 | — |
| 2025-07-31 | Geoffrey Michael Glass | Director | A | +11,000 | — |
| 2025-05-13 | Susan Rodriguez | Chief Operating Officer | A | +300,000 deriv. | — |
| 2025-03-07 | Thomas S McHugh | Chief Financial Officer | A | +12,600 | — |
| 2025-03-07 | Jerad G. Seurer | Gen. Counsel & Corp. Secretary | A | +14,700 | — |
| 2025-03-07 | Gregory J Divis | Chief Executive Officer | A | +52,000 | — |
| 2025-01-28 | Linda Palczuk | Director | G | −25,000 deriv. | — |
| 2025-01-22 | Linda Palczuk | Director | Buy | +5,000 | +$39.64K |
| 2025-01-14 | Peter J. Thornton | Director | Buy | +10,000 | +$80.45K |
| 2025-01-14 | Eric J Ende | Director | Buy | +30,000 | +$235.22K |
| 2024-12-27 | Linda Palczuk | Director | G | −3,500 | — |
| 2024-12-19 | Linda Palczuk | Director | A | +25,000 deriv. | — |
| 2024-12-16 | Thomas S McHugh | Chief Financial Officer | Buy | +2,300 | +$24.02K |
| 2024-12-12 | Thomas S McHugh | Chief Financial Officer | Buy | +5,000 | +$52.43K |
| 2024-12-10 | Linda Palczuk | Director | Buy | +3,000 | +$30.57K |
| 2024-12-10 | Gregory J Divis | Chief Executive Officer | Buy | +10,000 | +$99.71K |
| 2024-12-10 | Geoffrey Michael Glass | Director | Buy | +20,279 | +$199.64K |
| 2024-09-16 | Linda Palczuk | Director | G | −11,000 deriv. | — |
| 2024-09-13 | Geoffrey Michael Glass | Director | G | −11,000 deriv. | — |
| 2024-08-01 | Mark Anthony McCamish | Director | A | +11,000 | — |
| 2024-08-01 | Linda Palczuk | Director | A | +11,000 | — |
| 2024-08-01 | Geoffrey Michael Glass | Director | A | +11,000 | — |
| 2024-08-01 | Eric J Ende | Director | A | +11,000 | — |
| 2024-08-01 | Peter J. Thornton | Director | A | +11,000 | — |
| 2024-08-01 | Naseem Amin | Director | A | +11,000 | — |
| 2024-05-21 | Naseem Amin | Director | A | +49,500 deriv. | — |
| 2024-03-04 | Gregory J Divis | Chief Executive Officer | A | +600,000 deriv. | — |
| 2024-03-04 | Thomas S McHugh | Chief Financial Officer | A | +157,500 deriv. | — |
| 2024-03-04 | Richard J Kim | Chief Commercial Officer | A | +147,000 deriv. | — |
| 2024-01-16 | Thomas S McHugh | Chief Financial Officer | Buy | +2,000 | +$29.00K |
| 2023-12-29 | Mark Anthony McCamish | Director | Sell | −75,000 | −$1.09M |
| 2023-09-01 | Geoffrey Michael Glass | Director | G | −33,000 deriv. | — |
| 2023-09-01 | Linda Palczuk | Director | G | −33,000 deriv. | — |
Form 4 reports a change in beneficial ownership by an officer, director or 10%+ holder, and must be filed within two business days of the transaction — so this is close to real time, unlike the 45-day-lagged 13F institutional data.
Transaction codes matter more than the raw buy/sell count. Code P is an open-market purchase — an insider choosing to buy with their own money, which is the signal most research treats as informative. Code S is a sale, but sales are frequently pre-scheduled under a 10b5-1 plan or cover tax withholding on vesting equity, so a run of sales often says nothing directional. Codes A and M are grants and option exercises rather than open-market decisions.
Full filing history and per-insider positions are on the AVDL quote page; the site-wide leaderboard is on the insider transactions hub.
Market data may be delayed, incomplete, or inaccurate. Not a recommendation to buy, sell, or hold any security. Verify quotes with your broker before trading. See Terms §17.